Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

eHealth (EHTH) Preferred Stock Liabilities (2021 - 2025)

eHealth (EHTH) has 5 years of Preferred Stock Liabilities data on record, last reported at $382.1 million in Q4 2025.

  • For Q4 2025, Preferred Stock Liabilities rose 13.2% year-over-year to $382.1 million; the TTM value through Dec 2025 reached $382.1 million, up 13.2%, while the annual FY2025 figure was $382.1 million, 13.2% up from the prior year.
  • Preferred Stock Liabilities reached $382.1 million in Q4 2025 per EHTH's latest filing, up from $370.3 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $382.1 million in Q4 2025 and bottomed at $218.5 million in Q2 2021.
  • Average Preferred Stock Liabilities over 5 years is $293.1 million, with a median of $288.9 million recorded in 2023.
  • Peak YoY movement for Preferred Stock Liabilities: rose 13.2% in 2022, then increased 13.25% in 2024.
  • A 5-year view of Preferred Stock Liabilities shows it stood at $232.6 million in 2021, then grew by 13.2% to $263.3 million in 2022, then grew by 13.21% to $298.1 million in 2023, then grew by 13.24% to $337.5 million in 2024, then grew by 13.2% to $382.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Preferred Stock Liabilities were $382.1 million in Q4 2025, $370.3 million in Q3 2025, and $358.9 million in Q2 2025.